美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apnimed

28.03

-0.5200-1.82%

盘后：27.58-0.4500-1.61%19:59 EDT

成交量：24.63万

成交额：694.87万

市值：11.16亿

市盈率：-35.08

高：29.56

开：28.60

低：27.64

收：28.55

52周最高：35.29

52周最低：16.12

股本：3,982.32万

流通股本：1,200.00万

量比：0.59

换手率：2.05%

股息：- -

股息率：- -

每股收益(TTM):-0.7990

每股收益(LYR):-23.7581

净资产收益率：--

总资产收益率：-36.94%

市净率：-3.67

市盈率(LYR):-1.18

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Apnimed

交易所：

NASDAQ

成立时间：

2017

员工人数：

65

公司地址：

39 John F. Kennedy Street,4th Floor,Cambridge,Massachusetts,United States

官网：

http://www.apnimed.com

邮编：

02138

电话：

传真：

- -

简介：

Apnimed, Inc.于2017年6月根据特拉华州法律成立。该公司是一家后期临床制药公司，致力于发现、开发和商业化新型口服疗法，解决睡眠相关呼吸疾病的神经生物学问题。其唯一的临床候选产品Oxnimbi是一种研究性固定剂量抗呼吸暂停神经肌肉调节剂，结合新型抗毒蝇碱和选择性去甲肾上腺素再摄取抑制剂，旨在通过改善上气道肌肉活动来治疗阻塞性睡眠呼吸暂停，以维持气道通畅并防止睡眠期间气道塌陷，并于2026年4月向FDA提交了一份新药申请。

董事

名称

职位

Kevin R. Lind

Chief Executive Officer and Director

Chris Dimitropoulos

Independent Director

Gary Sender

Independent Director

Lawrence G. Miller

Director and Vice Chair

Paul Fonteyne

Independent Director

Paul Sekhri

Board Chair and Director

股东

名称

职位

Kevin R. Lind

Chief Executive Officer and Director

Dennis P. Molnar

Chief Operating Officer and President

Michael Kelly

Chief Financial Officer

Barry Wohl

Chief Business Officer

Beth Weinberg

Chief Regulatory and Safety Officer

Graham Goodrich

Chief Commercial Officer

John Cronin

Chief Medical Officer

Luigi Taranto Montemurro

Chief Scientific Officer

Steven Spector

Chief Legal Officer and Head of Corporate Affairs

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/APMD/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","market":"US","secType":"STK","nameCN":"Apnimed","latestPrice":28.03,"timestamp":1787342400000,"preClose":28.55,"halted":0,"volume":246332,"hourTrading":{"tag":"盘后","latestPrice":27.58,"preClose":28.03,"latestTime":"19:59 EDT","volume":7596,"amount":212454.87,"timestamp":1787356799532,"change":-0.45,"changeRate":-0.016054,"amplitude":0.016054},"delay":0,"changeRate":-0.018213660245183873,"floatShares":12000000,"shares":39823183,"eps":-0.799,"marketStatus":"休市中","change":-0.52,"latestTime":"08-21 16:00:00 EDT","open":28.6,"high":29.56,"low":27.64,"amount":6948736.033568,"amplitude":0.06725,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.799,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1785470400000,"exchange":"NASDAQ","adjPreClose":28.55,"preHourTrading":{"tag":"盘前","latestPrice":28.95,"preClose":28.55,"latestTime":"08:19 EDT","volume":93,"amount":2692.35,"timestamp":1787314764839,"change":0.4,"changeRate":0.014011,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":27.58,"preClose":28.03,"latestTime":"19:59 EDT","volume":7596,"amount":212454.87,"timestamp":1787356799532,"change":-0.45,"changeRate":-0.016054,"amplitude":0.016054},"volumeRatio":0.590759637683797},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APMD\",,,,,undefined,":{"symbol":"APMD","floatShares":12000000,"roa":"-36.94%","roe":"--","lyrEps":-23.758134,"volumeRatio":0.590759637683797,"shares":39823183,"dividePrice":0,"high":29.56,"amplitude":0.06725,"preClose":28.55,"low":27.64,"week52Low":16.12,"pbRate":"-3.67","psRate":"9.29","week52High":35.29,"institutionHeld":0,"latestPrice":28.03,"eps":-0.799,"divideRate":0,"volume":246332,"delay":0,"ttmEps":-0.799,"open":28.6,"prevYearClose":16,"prevWeekClose":31.75,"prevMonthClose":25,"prevQuarterClose":16,"fiveDayClose":31.75,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APMD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APMD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APMD","date":"2026-08-21","current":-35.081352,"percent":0,"low":-12.343549,"twenty":-9.895607,"median":-8.661063,"eighty":-7.942829,"high":-7.725991,"avg":-8.97211,"sd":1.217242,"marketCap":1582331874},"quantilePoints":[{"date":"2026-08-07","current":-8.661063,"twenty":-8.320585,"median":-7.986942,"eighty":-7.766377,"marketCap":1110270342},{"date":"2026-08-14","current":-8.943759,"twenty":-8.664791,"median":-8.256435,"eighty":-7.766377,"marketCap":1146509438},{"date":"2026-08-21","current":-12.343549,"twenty":-9.895607,"median":-8.661063,"eighty":-7.942829,"marketCap":1582331874}],"updateTime":1787514696485},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":573282303,"yearFounded":2017,"employeeNum":65,"address":"39 John F. Kennedy Street,4th Floor,Cambridge,Massachusetts,United States","zipCode":"02138","officePhone":"617 500 8880","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.apnimed.com","stockEarnings":[{"period":"1week","weight":-0.1172},{"period":"1month","weight":0.7519},{"period":"ytd","weight":0.7519}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Apnimed, Inc.于2017年6月根据特拉华州法律成立。该公司是一家后期临床制药公司，致力于发现、开发和商业化新型口服疗法，解决睡眠相关呼吸疾病的神经生物学问题。其唯一的临床候选产品Oxnimbi是一种研究性固定剂量抗呼吸暂停神经肌肉调节剂，结合新型抗毒蝇碱和选择性去甲肾上腺素再摄取抑制剂，旨在通过改善上气道肌肉活动来治疗阻塞性睡眠呼吸暂停，以维持气道通畅并防止睡眠期间气道塌陷，并于2026年4月向FDA提交了一份新药申请。","exchange":"NASDAQ","name":"Apnimed","nameEN":"Apnimed"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"APMD\",market:\"US\",,,undefined,":{"directors":[{"name":"Kevin R. Lind","position":"Chief Executive Officer and Director"},{"name":"Chris Dimitropoulos","position":"Independent Director"},{"name":"Gary Sender","position":"Independent Director"},{"name":"Lawrence G. Miller","position":"Director and Vice Chair"},{"name":"Paul Fonteyne","position":"Independent Director"},{"name":"Paul Sekhri","position":"Board Chair and Director"}],"executives":[{"name":"Kevin R. Lind","position":"Chief Executive Officer and Director"},{"name":"Dennis P. Molnar","position":"Chief Operating Officer and President"},{"name":"Michael Kelly","position":"Chief Financial Officer"},{"name":"Barry Wohl","position":"Chief Business Officer"},{"name":"Beth Weinberg","position":"Chief Regulatory and Safety Officer"},{"name":"Graham Goodrich","position":"Chief Commercial Officer"},{"name":"John Cronin","position":"Chief Medical Officer"},{"name":"Luigi Taranto Montemurro","position":"Chief Scientific Officer"},{"name":"Steven Spector","position":"Chief Legal Officer and Head of Corporate Affairs"}]}}}